BAT4706
- Generic Name
- BAT4706
Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- Bio-Thera Solutions
- Target Recruit Count
- 64
- Registration Number
- NCT05148325
- Locations
- 🇨🇳
Beijing cancer hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath